Oruka Therapeutics IncNASDAQ:ORKA
- LAST PRICE20.7500
- TODAY'S CHANGE (%)0.2500 (1.2195%)
- Bid / Lots18.8500/ 1
- Ask / Lots22.7400/ 1
- Open / Previous Close20.4100 / 20.5000
- Day Range
- 52 Week Range
- Volume331,101
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ORKA |
|---|---|---|
| 09:32 ET | 213 | 20.41 |
| 09:50 ET | 200 | 20.48 |
| 09:55 ET | 200 | 20.62 |
| 09:57 ET | 104 | 20.725 |
| 10:00 ET | 600 | 20.96 |
| 10:02 ET | 100 | 20.93 |
| 10:15 ET | 1031 | 20.55 |
| 10:31 ET | 343 | 20.32 |
| 10:33 ET | 100 | 20.52 |
| 10:36 ET | 100 | 20.32 |
| 10:42 ET | 100 | 20.38 |
| 10:47 ET | 200 | 20.39 |
| 10:49 ET | 100 | 20.355 |
| 10:51 ET | 100 | 20.46 |
| 10:54 ET | 100 | 20.451 |
| 10:56 ET | 13747 | 20.5 |
| 10:58 ET | 1001 | 20.58 |
| 11:00 ET | 100 | 20.52 |
| 11:02 ET | 200 | 20.6 |
| 11:03 ET | 100 | 20.5 |
| 11:05 ET | 100 | 20.51 |
| 11:07 ET | 3608 | 20.7 |
| 11:14 ET | 100 | 20.55 |
| 11:20 ET | 100 | 20.55 |
| 11:21 ET | 200 | 20.6701 |
| 11:23 ET | 100 | 20.55 |
| 11:27 ET | 100 | 20.555 |
| 11:36 ET | 100 | 20.5 |
| 11:38 ET | 400 | 20.56 |
| 11:39 ET | 100 | 20.605 |
| 11:43 ET | 100 | 20.605 |
| 11:45 ET | 100 | 20.605 |
| 11:54 ET | 200 | 20.605 |
| 11:56 ET | 100 | 20.605 |
| 11:57 ET | 1861 | 20.7 |
| 11:59 ET | 1186 | 20.7 |
| 12:03 ET | 1066 | 20.99 |
| 12:08 ET | 100 | 20.845 |
| 12:21 ET | 500 | 21 |
| 12:24 ET | 141 | 20.99 |
| 12:30 ET | 100 | 20.87 |
| 12:33 ET | 100 | 20.85 |
| 12:35 ET | 254 | 20.85 |
| 12:37 ET | 800 | 20.95 |
| 12:42 ET | 200 | 20.86 |
| 12:46 ET | 3590 | 20.855 |
| 12:48 ET | 2200 | 20.88 |
| 12:50 ET | 16830 | 20.86 |
| 12:51 ET | 3576 | 20.94 |
| 12:53 ET | 1100 | 20.85 |
| 01:02 ET | 100 | 20.9 |
| 01:06 ET | 5915 | 20.825 |
| 01:08 ET | 20455 | 20.8 |
| 01:09 ET | 88000 | 20.85 |
| 01:13 ET | 2197 | 20.89 |
| 01:26 ET | 245 | 20.89 |
| 01:27 ET | 1677 | 20.9 |
| 01:29 ET | 169 | 20.94 |
| 01:42 ET | 100 | 20.89 |
| 01:45 ET | 100 | 20.56 |
| 01:56 ET | 200 | 20.58 |
| 02:00 ET | 169 | 20.55 |
| 02:02 ET | 200 | 20.52 |
| 02:03 ET | 400 | 20.8 |
| 02:05 ET | 313 | 20.745 |
| 02:14 ET | 100 | 20.73 |
| 02:16 ET | 200 | 20.75 |
| 02:25 ET | 475 | 20.7106 |
| 02:30 ET | 500 | 20.71 |
| 02:32 ET | 200 | 20.725 |
| 02:34 ET | 100 | 20.815 |
| 02:41 ET | 200 | 20.71 |
| 02:48 ET | 85475 | 20.81 |
| 02:50 ET | 131 | 20.81 |
| 02:52 ET | 100 | 20.73 |
| 02:54 ET | 3670 | 20.8 |
| 02:56 ET | 445 | 20.7 |
| 03:01 ET | 201 | 20.795 |
| 03:06 ET | 200 | 20.71 |
| 03:08 ET | 100 | 20.705 |
| 03:10 ET | 102 | 20.795 |
| 03:14 ET | 104 | 20.795 |
| 03:17 ET | 801 | 20.73 |
| 03:19 ET | 103 | 20.795 |
| 03:24 ET | 101 | 20.805 |
| 03:26 ET | 300 | 20.73 |
| 03:28 ET | 382 | 20.805 |
| 03:30 ET | 100 | 20.72 |
| 03:32 ET | 250 | 20.71 |
| 03:35 ET | 1656 | 20.7 |
| 03:37 ET | 500 | 20.69 |
| 03:48 ET | 727 | 20.555 |
| 03:53 ET | 900 | 20.54 |
| 03:55 ET | 2055 | 20.54 |
| 03:57 ET | 1508 | 20.54 |
| 04:00 ET | 6162 | 20.75 |
Nov 19, 2024
Oruka Therapeutics to Present at Piper Sandler's 36th Annual Healthcare Conference, from 8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 13, 2024
Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:25PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:25PM ET on Wednesday Nov 13, 2024 by Dow JonesPress Release: Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:25PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:25PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 4, 2024
Oruka Therapeutics to Present at Multiple November Investor Conferences, from 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
7:00AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
DJ Oruka Therapeutics Price Target Maintained With a $45.00/Share by HC Wainwright & Co., from 7:40AM ET on Thursday Oct 31, 2024 by Dow Jones
7:40AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oruka Therapeutics Inc | 717.5M | -3.5x | --- |
CARGO Therapeutics Inc | 722.1M | -4.7x | --- |
Cullinan Therapeutics Inc | 711.5M | -4.4x | --- |
Erasca Inc | 734.5M | -3.3x | --- |
Oculis Holding AG | 615.7M | -7.4x | --- |
Replimune Group Inc | 755.0M | -4.9x | --- |
Company Information
Oruka Therapeutics, Inc., formerly ARCA biopharma, Inc., is a biotechnology company. The Company is engaged in developing novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis. It is advancing a proprietary portfolio of potential antibodies that target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. The Company’s lead programs include ORKA-001 and ORKA-002, which are designed to block cytokines in the pathogenesis of psoriasis and other inflammatory diseases. ORKA-001 is a potentially monoclonal antibody designed to inhibit IL-23p19 for the treatment of psoriasis. ORKA-001 targets the p19 subunit of interleukin-23 (IL-23p19). ORKA-002 is a potentially monoclonal antibody designed to inhibit IL-17A/F for the treatment of psoriasis, psoriatic arthritis, and other conditions. ORKA-002 targets interleukin-17A and interleukin-17F (IL-17A/F).
Contact Information
- Headquarters
- 10170 Church Ranch Way, Suite 100WESTMINSTER, CO, United States 80021
- Phone
- 720-940-2200
- Fax
- 302-655-5049
Executives
- Non-Executive Independent Chairman of the Board
- Samarth Kulkarni
- President, Chief Executive Officer, Director
- Lawrence Klein
- Senior Vice President - Finance, Treasurer
- Arjun Agarwal
- General Counsel, Secretary
- Paul Quinlan
- Chief Medical Officer
- Joana Goncalves
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $717.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.80 |
EPS | $-5.97 |
Book Value | $30.64 |
P/E Ratio | -3.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
